^
BIOMARKER:

ROS1 rearrangement

i
Other names: ROS1, ROS Proto-Oncogene 1 Receptor Tyrosine Kinase, V-Ros Avian UR2 Sarcoma Virus Oncogene Homolog 1, C-Ros Oncogene 1 Receptor Tyrosine Kinase, Proto-Oncogene Tyrosine-Protein Kinase ROS, Proto-Oncogene C-Ros-1, MCF3, ROS, V-Ros UR2 Sarcoma Virus Oncogene Homolog 1 (Avian), ROS Proto-Oncogene 1 Receptor Tyrosine Kinase, Transmembrane Tyrosine-Specific Protein Kinase, Receptor Tyrosine Kinase C-Ros Oncogene 1, C-Ros Receptor Tyrosine Kinase, Proto-oncogene C-Ros, C-Ros-1
Entrez ID:
ROS1 rearrangement
NSCLC
ceritinib
Sensitive: A2 - Guideline
ROS1 rearrangement
NSCLC
crizotinib
Sensitive: A2 - Guideline
ROS1 rearrangement
NSCLC
entrectinib
Sensitive: A2 - Guideline
ROS1 rearrangement
NSCLC
lorlatinib
Sensitive: A2 - Guideline
ROS1 rearrangement
Lung Cancer
crizotinib
Sensitive: C2 – Inclusion Criteria
ROS1 rearrangement
Lung Non-Squamous Non-Small Cell Cancer
crizotinib
Sensitive: C2 – Inclusion Criteria
ROS1 rearrangement
LUAD
crizotinib
Sensitive: C3 – Early Trials
ROS1 rearrangement
LUAD
Tyrosine kinase inhibitor
Sensitive: C3 – Early Trials
ROS1 rearrangement
NSCLC
brigatinib
Sensitive: C3 – Early Trials
ROS1 rearrangement
NSCLC
Immunotherapy
Sensitive: C3 – Early Trials
ROS1 rearrangement
LUAD
ceritinib
Sensitive: C4 – Case Studies